Cargando…

Patient-reported Outcomes for Clinical Trials in Idiopathic Pulmonary Fibrosis: New Opportunities to Understand How Patients Feel and Function

Detalles Bibliográficos
Autores principales:	Holland, Anne E., Dowman, Leona, Smallwood, Natasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737578/ https://www.ncbi.nlm.nih.gov/pubmed/32749856 http://dx.doi.org/10.1164/rccm.202007-2775ED

Ejemplares similares

Self-management interventions for people with pulmonary fibrosis: a scoping review
por: Lee, Joanna Y.T., et al.
Publicado: (2023)

Cough in Idiopathic Pulmonary Fibrosis
por: Mann, Jennifer, et al.
Publicado: (2021)

Six-minute walk test in patients with idiopathic pulmonary fibrosis
por: Baddini-Martinez, José Antônio
Publicado: (2018)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

How many patients with idiopathic pulmonary fibrosis are there in Brazil?
por: Baddini-Martinez, José, et al.
Publicado: (2015)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

Beyond standard care?—idiopathic pulmonary fibrosis patients’ perception of care coordinators
por: Hagmeyer, Lars, et al.
Publicado: (2020)

Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. Echoes of the Past, Lessons for the Future
por: Nathan, Steven D.
Publicado: (2019)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Recent advances in understanding idiopathic pulmonary fibrosis
por: Daccord, Cécile, et al.
Publicado: (2016)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
por: O’Dwyer, David N., et al.
Publicado: (2019)

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?
por: Wilson, Carole L., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
por: Morais, António
Publicado: (2019)

Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten
por: Maher, Toby M.
Publicado: (2021)

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
por: Morice, Alyn H.
Publicado: (2022)

Arrearages—How to “Feel Better”
Publicado: (1880)

Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trial
por: Holland, Anne E, et al.
Publicado: (2020)

Imaging: how to recognise idiopathic pulmonary fibrosis
por: Devaraj, Anand
Publicado: (2014)

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives
por: Swigris, Jeffrey J, et al.
Publicado: (2005)

Goldilocks and the Three Trials: Clinical Trials Targeting the α(v)β(6) Integrin in Idiopathic Pulmonary Fibrosis
por: Sime, Patricia, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management
por: Baldi, Bruno Guedes
Publicado: (2017)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
por: Poletti, Venerino
Publicado: (2014)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Assessing the Burden and Prognostic Value of Cough in Idiopathic Pulmonary Fibrosis
por: Johnston, Janet, et al.
Publicado: (2023)

Updates in the New Guidelines for Idiopathic Pulmonary Fibrosis: Role of Cryobiopsy
por: Cascante Rodrigo, Jose Antonio, et al.
Publicado: (2022)

Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link?
por: Polverino, Francesca
Publicado: (2023)

Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis
por: Molina-Molina, Maria
Publicado: (2019)

Lost in Translation: Endoplasmic Reticulum–Mitochondria Crosstalk in Idiopathic Pulmonary Fibrosis
por: Bueno, Marta, et al.
Publicado: (2020)

Idiopathic Pulmonary Fibrosis and Lung Cancer: Finding Similarities within Differences
por: Reyfman, Paul A., et al.
Publicado: (2019)

The Role of Surgical Lung Biopsy in Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
por: Limper, Andrew H.
Publicado: (2019)

Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms
por: Kreuter, Michael, et al.
Publicado: (2020)

Do Circulating Monocytes Promote and Predict Idiopathic Pulmonary Fibrosis Progression?
por: Fernandez, Isis E., et al.
Publicado: (2021)

Targeting Human Herpesviruses: An Effective Strategy for Treating Idiopathic Pulmonary Fibrosis?
por: Maher, Toby M.
Publicado: (2021)

Uncovering the Epidemiology of Idiopathic Pulmonary Fibrosis in the Veterans Affairs Health System
por: Tighe, Robert M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9mvc94hga1km5naam7uivaiho2